Concepedia

Arzu Didem Yalçın

AD

18

Publications

425

Citations

13

H-Index

2007

Active since

Affiliations

Antalya Eğitim ve Araştırma Hastanesi(Current)

Akdeniz University

Heidelberg University

Dokuz Eylül University

German Cancer Research Center

Arzu Didem Yalçın is an author at Antalya Eğitim ve Araştırma Hastanesi specializing in medicine, cancer research, and autoimmune disease.

Top concepts

Publications per year

2007–2022

18

Publications

18

A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels

Arzu Didem Yalçın · Immunopharmacology and Immunotoxicology · 2015 · 57 citations

Omalizumab (anti-IgE) therapy in the asthma–COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels

Arzu Didem Yalçın · Immunopharmacology and Immunotoxicology · 2016 · 57 citations

D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment

Arzu Didem Yalçın, Betül Çelik, Saadet Gümüşlü · Expert Opinion on Biological Therapy · 2013 · 34 citations

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels

Arzu Didem Yalçın, Aykut Çilli, Ludwig G. Strauss et al. · Expert Opinion on Biological Therapy · 2013 · 26 citations

Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1<b>β</b>and sCD200 in cases of Samter's syndrome: 36 months follow-up

Arzu Didem Yalçın, Seçil Uçar, Saadet Gümüşlü et al. · Immunopharmacology and Immunotoxicology · 2013 · 25 citations

Rows per page

1–5 of 18